Sobha’s Sales Jumps In Q1 Even As Price Realisations Decline
Sobha Ltd. sold more residential units in the first quarter even as average price realisations declined.
Sales volume of its residential units jumped 11 percent in the quarter from 0.96 million square feet to 1.06 million square feet on a yearly basis, the Bengaluru-based real estate firm said in an exchange filing. The city contributes almost 80 percent to the company's total revenue.
The company's share in total sales value increased 8 percent to Rs 660.6 crore in the first quarter, according to its filing.
Average price realisation, however, fell 8 percent to Rs 7,312 per square feet due to change in product mix across various projects, the real estate developer said.
Still, Deutsche Bank remains optimistic. Bengaluru is one of the best placed residential markets in India, Bijay Kumar, research analyst at the brokerage, wrote in a note last month. The developer, he had said, is expected to gain market share in a consolidating market with a strong demand in housing units in the range of Rs 1-2 crore segment continuing in financial year 2020.
The company launched a total of 0.61 million square feet of projects during the quarter and also entered in a joint development agreement for residential development in Hyderabad, according to its exchange filing.
Shares of Sobha rose 1.51 percent on July 4 compared to a 0.91 percent jump in the Nifty Realty Index. 92 percent of analysts have a ‘Buy' rating on the stock, while the 12-month return potential stands at 6.3 percent, according to Bloomberg Data.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.
-
Why Amazon And Flipkart Are Struggling To Beat Meesho In India's Smaller Cities
With 274 million users and lowest-cost logistics, Meesho is defending its value commerce crown against giants like Amazon and Flipkart.
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Swiggy vs Eternal: Food Delivery's Two Rivals Are No Longer In The Same Race
Eternal is building a private AI assistant, dark.ai. Swiggy is still working out how to make Instamart pay, with an operating loss of Rs 895 crore in the July-September quarter while Blinkit stayed profitable.
-
Where You Live Shapes How You Get To Work | The Reason Why
Two-wheelers are the most popular way to get to work in India, accounting for nearly 43% of workplace commutes.
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
-
India Exports Capital. Why Not Export Trusteeship?
The big question, then, is whether India can build an institution that global borrowers, investors, banks, and lawyers can trust, even without an Indian connection.